Literature DB >> 6377437

Methodologic issues in hospital epidemiology. III. Investigating the modifying effects of time and severity of underlying illness on estimates of cost of nosocomial infection.

J Freeman, J E McGowan.   

Abstract

Published estimates of extra cost and prolongation of hospital stay attributed to nosocomial infection obtained from epidemiologic comparisons are almost twice as large as judgements in studies based on subjective impressions. It is possible that this disparity may result from confounding by time and severity of underlying illness. Whether the effects of time and secondary disease diagnoses modified the results of an epidemiologic comparison of infected patients and comparison subjects matched on primary diagnosis and operation have been investigated. Whereas the average prolongation of hospital stay in a prevalence series of patients with nosocomial infection was 13.3 days, the average prolongation for the corresponding incidence series of infections from the same study population was only 7.3 days, or about one-half as long. No substantive changes resulted from adjusting for duration of exposure to hospital prior to infection. Five selected secondary diagnoses had the potential for substantial confounding effects on epidemiologic comparisons but had little overall effect on the estimates in this study. The large size of our estimates in both prevalence and incidence series is not the result of residual confounding by the effects of time or secondary disease diagnoses. Results from prevalence and incidence series must be clearly distinguished because the same events will be perceived differently in the two types of series.

Entities:  

Mesh:

Year:  1984        PMID: 6377437     DOI: 10.1093/clinids/6.3.285

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

1.  Prevalence studies in nosocomial infections.

Authors:  R C Spencer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

Review 2.  Epidemiology, therapy and costs of nosocomial infection.

Authors:  R Gálvez-Vargas; A Bueno-Cavanillas; M García-Martín
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 3.  An overview of nosocomial infections, including the role of the microbiology laboratory.

Authors:  T G Emori; R P Gaynes
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

4.  On the role of length of stay in healthcare-associated bloodstream infection.

Authors:  Christie Y Jeon; Matthew Neidell; Haomiao Jia; Matt Sinisi; Elaine Larson
Journal:  Infect Control Hosp Epidemiol       Date:  2012-10-19       Impact factor: 3.254

5.  Estimation of prolongation of hospital stay attributable to nosocomial infections: new approaches based on multistate models.

Authors:  G Schulgen; M Schumacher
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

Review 6.  Factors associated with variation in estimates of the cost of resistant infections.

Authors:  Bevin Cohen; Elaine L Larson; Patricia W Stone; Matthew Neidell; Sherry A Glied
Journal:  Med Care       Date:  2010-09       Impact factor: 2.983

7.  Reliability of reporting nosocomial infections in the discharge abstract and implications for receipt of revenues under prospective reimbursement.

Authors:  R M Massanari; K Wilkerson; S A Streed; W J Hierholzer
Journal:  Am J Public Health       Date:  1987-05       Impact factor: 9.308

8.  Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization.

Authors:  A A Vegas; V M Jodra; M L García
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

9.  Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit.

Authors:  I Kappstein; G Schulgen; U Beyer; K Geiger; M Schumacher; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.